维普中文期刊产品整合服务
910篇 您的检索式:作者名="Suarez M"
    题名 作者 年代 出处 被引量
1Conversion from calcineurin inhibitors to mTOR inhibitors stabilizes diabetic and hypertensive nephropathy after liver transplant显示文摘AIM: To investigate if conversion to the mammalian target of rapamycin inhibitors(mTORi) improves renal function in diabetic and/or hypertensive liver transplant patients immunosuppressed with tacrolimus or cyclosporine.METHODS: The study included 86 liver graft recipients immunosuppressed with mTORi treatment after orthotopic liver transplantation(OLT), including all liver recipients with worsening renal function before conversion to mTORi(n = 55 patients) and recipients with normal renal function who converted to m TORi for other reasons(n = 31 patients). We identified patients with diabetes mellitus(n = 28), arterial hypertension(n = 27), proteinuria(n = 27) and all three factors(n = 8)(some patients have hypertension and diabetes and no proteinuria). The primary endpoint was evolution in renal function defined as the development in plasma creatinine as a function of diabetes mellitus(DM), hypertension(HT) or proteinuria. We required elevated serum creatinine for at least two weeks to define renal dysfunction.RESULTS: Only patients that converted because of renal failure with plasma creatinine levels > 1.5 mg/dL showed an improvement of renal function(2.14 to 1.77 mg/dL)(P = 0.02). Patients with DM showed no improvement of serum creatinine levels(1.31 mg/dL to 1.37 mg/dL) compared with non DM patients(1.31 mg/dL to 1.15 mg/dL)(P = 0.01), HT patients(1.48 mg/dL to 1.5 mg/dL) with non HT patients(1.21mg/d L to 1.08 mg/dL) and patients with proteinuria(1.44 mg/dL to 1.41 mg/dL) and no proteinuria(1.31 mg/dL to 1.11 mg/dL). CONCLUSION: In OLT recipients with diabetes or hypertensive nephropathy, conversion to m TORi does not improve renal function but stabilizes plasma levels of creatinine. Proteinuria is not a contraindication to conversion to m TORi; it also stabilizes renal function. Conversion to m TORi should only be avoided in patients with diabetes, hypertension and proteinuria.José M álamo Claudia Olivares Lydia Barrera Luis M Marín Gonzalo Suarez Carmen Bernal Juan Serrano Jordi Muntané Francisco J Padillo Miguel A Gómez 2015World Journal of Transplantation2015,5,1:6
2叶酸与甲酰四氢叶酸用于减少甲氨蝶呤治疗副作用(摘要)显示文摘1 背景 甲氨蝶呤用于治疗许多风湿病,其短期疗效已被证实。但毒性使不少患者不能从中受益,其中叶酸缺乏可增加其毒性。类风湿关节炎患者常有叶酸缺乏,经甲氨蝶呤治疗后叶酸储备就进一步减少。甲氨蝶呤的胃肠道和血液学副作用都与叶酸缺乏有关,可以预见,叶酸补充疗法将有助改善低剂量甲氨蝶呤治疗的副作用。对此,已有不少试验开展,并提出不同的副作用减少率。Ortiz Z SheaB Suarez Almazor M Moher D Wells G Tugwell P 姚如愚 2001循证医学2001,1,1:4
3Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis显示文摘Rayner Katey J Sheedy Frederick J Esau Christine C Hussain Farah N Temel Ryan E Parathath Saj van Gils Janine M Rayner Alistair J Chang Aaron N Suarez Yajaira Fernandez-Hernando Carlos Fisher Edward A Moore Kathryn J 2011Journal of Clinical Investigation2011,,7:2
4Comparative FT-IR study of the removal of octahedral cations and structural modifications during acid treatment of several silicates显示文摘VICENTE-RODRIGUEZ M A SUAREZ M BANARESMUNOZ M A 1996Spectrochimica Acta Part A1996,52,:2
5COVID-19 and neurologic manifestations:a synthesis from the child neurologist’s corner显示文摘Background Since December 2019,the SARS-CoV-2 virus has been a global health issue.The main clinical presentation of this virus is a flu-like disease;however,patients with diverse neurologic manifestations have also been reported.In this review,we attempt to summarize,discuss and update the knowledge of the neurologic manifestations in the pediatric population affected by SARS-CoV-2 infection and the pandemic’s effects in children with neurologic diseases.Data sources This review analyzes studies found on the PubMed database using the following keywords:Neurologic manifestations COVID-19,Neurological COVID-19,coronavirus,SARS-CoV-2,pediatric COVID-19,COVID-19 in children,MIS-C,Pediatric Inflammatory Multisystem Syndrome,Guillain BarréSyndrome,Stroke,ADEM,and Anti-NMDA encephalitis.All studies cited were published between 2004 and 2022,and represent the most relevant articles in the field.The World Health Organization COVID-19 online dashboard was assessed to obtain updated epidemiological data.Results The most common neurologic symptoms in the pediatric population are headache,seizures,encephalopathy,and muscle weakness.These can be present during COVID-19 or weeks after recovering from it.Children who presented with multi-system inflammatory syndrome had a higher incidence of neurologic manifestations,which conferred a greater risk of morbidity and mortality.Several neuro-pathophysiological mechanisms have been proposed,including direct virus invasion,hyper-inflammatory reactions,multi-systemic failure,prothrombotic states,and immune-mediated processes.On the other hand,the COVID-19 pandemic has affected patients with neurologic diseases,making it challenging to access controls,treatment,and therapies.Conclusions Various neurologic manifestations have been associated with children’s SARS-CoV-2 infection.It is important to identify and give them proper and opportune treatment because they can be potentially grave and life-threatening;some can lead to long-lasting sequelae.Different neuro-pathophysiological mechanisms have been proposed,however,a causal relationship between SARS-CoV-2 infection and neurologic manifestations remains to be proven.Patients with neurologic diseases are especially affected by COVID-19,not only by the disease itself but also by its complications and pandemic management measures.Carolina Valderas Gastón Méndez Alejandra Echeverría Nelson Suarez Katherin Julio Francisca Sandoval 2022World Journal of Pediatrics2022,18,6:2
6Structural features of the avian influenza virus hemagglutinin that influence virulence 显示文摘Perdue M L Suarez D L 2000Veterinary' Microbiology2000,74,:1
7Ni- tric oxide synthase inhibition and food intake effects on motivation to eat and in female mice 显示文摘MORLEY J E FARR S A SUAREZ M D 1995Pharma- cology Biochemistry and Behavior1995,50,3:1
8Effect of age of feed restriction and microelement supplementa- tion to control ascites on production and carcass charac- teristics of broilers 显示文摘Camacho M A Suarez M E Herrera J G 2004Poultry Science2004,,83:1
9A simple framework for examing the interannual variability of land surface moisture flux-es显示文摘Koster R D Suarez M J 0,,12:1
10Structural features of the avian influenza virus hemagglutinin that influence virulence 显示文摘Perdue M L Suarez D L 2000Vet Mieobiol2000,74,12:1
11Isolation and characterization of PRA1,a trypsin -like protease from the biocontrol agent Trichoderma har-zianum CECT 2413 displaying nematicidal activity显示文摘SUAREZ B REY M CASTILLO P 2004Appl Microbiol Bio-technol2004,,:1
12Design and Performance Analysis of a Massively Parallel Atmospheric General Circulation Model显示文摘Schaffer D S Suarez M J 2000Scientific Programming2000,8,1:1
13Comparative FT-IR study of the removal of octahedral cations and structural modigications during acid treatment of several silicates显示文摘Vicente-Rodríguez M A Suarez M Banares-Munoz M A 1996Spectrochimica Acta Part A1996,,52:1
14Value of the ankle-brachial index in cardiovascular risk stratification of patients without known atherotrom-hotic disease显示文摘MANZANO L MOSTAZA J M SUAREZ C 2007Med Clin (Barc)2007,128,:1
15An effcient thermal infrared radiation parameterization for use in general circulation models 显示文摘Chou M D Suarez M J 1994NASA Tech Memo 1046061994,3,:1
16Immediate andfollow-up findings after stentt treatment for severe eoareta- tion of aorta显示文摘Suarez de Lezo J Pan M Romero M 1999Am J Cardiol1999,83,:1
17Balloon-expandable stent repair of severe coarctation of aorta显示文摘Suarez de Lezo J Pan M Romero M 1995Am Heart J1995,129,:1
18Mannan-binding lectin pathway deficiencies and invasive fungal infections following allogeneie stem cell transplantation显示文摘Granell M Urbano-Ispizua A Suarez B 2006Exp Hematol2006,34,10:1
19Dominant designs and the survival of firms显示文摘SUAREZ F F UTTERBACK J M 1995Strategic Management Journal1995,16,6:1
20Evaluation of BTEX remediation by natural attenuation at a coastal facility 显示文摘Suarez M P Rifai H S 2002Ground Water Monitoring Remediation2002,,22:1
返回顶部 每页显示:
共46页 首页 上一页 第1页 下一页 末页 /46 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费